Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Labcorp logoLabcorp LH

The company said revenue from continuing operations for Q4 2024 was $3.33 billion ($3.03 billion in the same quarter last year), and full-year revenue was $13.01 billion ($12.16 billion a year earlier). Diluted EPS was $1.70 for Q4 ($(1.95) in the same quarter last year) and $8.84 for the full year ($4.33 a year earlier).

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary

  1. The company said revenue from continuing operations for Q4 2024 was $3.33 billion ($3.03 billion in the same quarter last year), and full-year revenue was $13.01 billion ($12.16 billion a year earlier). Diluted EPS was $1.70 for Q4 ($(1.95) in the same quarter last year) and $8.84 for the full year ($4.33 a year earlier).

  2. Labcorp said adjusted operating income for Q4 2024 was $423.2 million ($394.9 million a year earlier), and adjusted operating margin was 12.7% (13.0% a year earlier). The company cited Invitae as the reason adjusted operating margin declined.

  3. Labcorp said continuing-operations operating cash flow for 2024 was $1,585.8 million and free cash flow was $1,095.9 million. For the full year, the company used $839.0 million for acquisitions, $243.1 million for dividends and $250.1 million for share repurchases.

  4. Labcorp gave its outlook for 2025, with full-year revenue of $13.88 billion to $14.05 billion, adjusted EPS of $15.60 to $16.40, and free cash flow of $1.10 billion to $1.25 billion. The company said the outlook assumes foreign exchange rates effective as of December 31, 2024.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Quarterly and Full-Year Revenue and Diluted EPS for Q4 2024

The company said revenue from continuing operations for Q4 2024 was $3.33 billion ($3.03 billion in the same quarter last year), and full-year revenue was $13.01 billion ($12.16 billion a year earlier). Diluted EPS was $1.70 for Q4 ($(1.95) in the same quarter last year) and $8.84 for the full year ($4.33 a year earlier).

Source · Based on the filing body and exhibits

Adjusted Operating Margin Changes and Company Explanation

Labcorp said adjusted operating income for Q4 2024 was $423.2 million ($394.9 million a year earlier), and adjusted operating margin was 12.7% (13.0% a year earlier). The company cited Invitae as the reason adjusted operating margin declined.

Source · Based on the filing body and exhibits

Cash Flow and Capital Allocation

Labcorp said continuing-operations operating cash flow for 2024 was $1,585.8 million and free cash flow was $1,095.9 million. For the full year, the company used $839.0 million for acquisitions, $243.1 million for dividends and $250.1 million for share repurchases.

Source · Based on the filing body and exhibits

2025 Full-Year Outlook (Guidance)

Labcorp gave its outlook for 2025, with full-year revenue of $13.88 billion to $14.05 billion, adjusted EPS of $15.60 to $16.40, and free cash flow of $1.10 billion to $1.25 billion. The company said the outlook assumes foreign exchange rates effective as of December 31, 2024.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗
Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.